Paul S. Mischel is a neuropathologist and cancer biologist who has served on the UCLA School of Medicine Faculty since joining the Department of Pathology and Laboratory Medicine in 1998. He became an associate professor in 2004. Dr. Mischel graduated with a B.A. in Philosophy from the University of Pennsylvania in 1984. He earned his M.D. from Cornell University Medical College in 1991, graduating with Alpha Omega Alpha Honors. He did his residency training in Anatomic Pathology and his fellowship in Neuropathology at UCLA.

Following this, he did post-doctoral training in the laboratory of Dr. Louis F. Reichardt at the Howard Hughes Medical Institute of UCSF, working on Trk receptor signaling in brain development. Since joining the faculty at UCLA, Dr. Mischel’s research interests have focused on the molecular pathogenesis of brain tumors and the development and implementation of novel targeted therapies. By studying gene expression networks and protein signaling networks in glioblastoma, his laboratory is developing new approaches to identifying molecular signatures that can be used to inform treatment decisions.